CCL3L1 and CCR5 influence cell-mediated immunity and affect HIV-AIDS pathogenesis via viral entry-independent mechanisms (Q43955957)

28 November 2017

title

CCL3L1 and CCR5 influence cell-mediated immunity and affect HIV-AIDS pathogenesis via viral entry-independent mechanisms (English)

1 reference

28 November 2017

0 references

1 reference

28 November 2017

1 reference

28 November 2017

Brian K Agan

0 references

Frederick M Hecht

0 references

Andrew Lloyd

0 references

Steven G Deeks

1 reference

28 November 2017

Bruce D Walker

1 reference

28 November 2017

Florencia Pereyra

1 reference

28 November 2017

Manju Mamtani

1 reference

28 November 2017

Judith Delmar

1 reference

28 November 2017

Seema S Ahuja

1 reference

28 November 2017

Matthew J Dolan

1 reference

28 November 2017

Hemant Kulkarni

1 reference

28 November 2017

Jose F Camargo

1 reference

28 November 2017

Weijing He

1 reference

28 November 2017

Alison Smith

1 reference

28 November 2017

Toshiyuki Miura

1 reference

28 November 2017

Andrea Mangano

1 reference

28 November 2017

Luisa Sen

1 reference

28 November 2017

Rosa Bologna

1 reference

28 November 2017

Robert A Clark

1 reference

28 November 2017

Stephanie A Anderson

1 reference

28 November 2017

Robert J O'Connell

1 reference

28 November 2017

Jeffrey Martin

1 reference

28 November 2017

Sunil K Ahuja

1 reference

28 November 2017

language of work or name

English

0 references

publication date

21 October 2007

1 reference

28 November 2017

1 reference

28 November 2017

1 reference

28 November 2017

1 reference

28 November 2017

page(s)

1324-1336

1 reference

Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection

28 November 2017

cites work

1 reference

Delayed-type hypersensitivity skin testing predicts progression to AIDS in HIV-infected patients

21 January 2018

1 reference

In vitro T cell function, delayed-type hypersensitivity skin testing, and CD4+ T cell subset phenotyping independently predict survival time in patients infected with human immunodeficiency virus

21 January 2018

1 reference

Delayed-type hypersensitivity skin tests are an independent predictor of human immunodeficiency virus disease progression. Department of Veterans Affairs Cooperative Study Group

21 January 2018

1 reference

T cell dynamics in HIV-1 infection

21 January 2018

1 reference

7 January 2021

Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells.

1 reference

7 January 2021

Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection

1 reference

7 January 2021

Paucity of CD4+CCR5+ T cells is a typical feature of natural SIV hosts

1 reference

7 January 2021

The CCR5 and CXCR4 coreceptors--central to understanding the transmission and pathogenesis of human immunodeficiency virus type 1 infection

1 reference

7 January 2021

Biology of CCR5 and its role in HIV infection and treatment

1 reference

7 January 2021

LD78beta, a non-allelic variant of human MIP-1alpha (LD78alpha), has enhanced receptor interactions and potent HIV suppressive activity

1 reference

7 January 2021

The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility

1 reference

7 January 2021

Influence of host genetic variation on susceptibility to HIV type 1 infection

1 reference

7 January 2021

Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression

1 reference

7 January 2021

Concordance between the CC chemokine receptor 5 genetic determinants that alter risks of transmission and disease progression in children exposed perinatally to human immunodeficiency virus

1 reference

7 January 2021

Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypes

1 reference

7 January 2021

Genetic acceleration of AIDS progression by a promoter variant of CCR5.

1 reference

7 January 2021

Combined effect of CCR5-Delta32 heterozygosity and the CCR5 promoter polymorphism -2459 A/G on CCR5 expression and resistance to human immunodeficiency virus type 1 transmission

1 reference

7 January 2021

CCR5 promoter polymorphism determines macrophage CCR5 density and magnitude of HIV-1 propagation in vitro

1 reference

7 January 2021

Beta chemokines costimulate lymphocyte cytolysis, proliferation, and lymphokine production

1 reference

7 January 2021

Macrophage-derived dendritic cells have strong Th1-polarizing potential mediated by beta-chemokines rather than IL-12

1 reference

7 January 2021

Beta-chemokines inhibit activation-induced death of lymphocytes from HIV-infected individuals

1 reference

7 January 2021

Chemokines as regulators of T cell differentiation.

1 reference

7 January 2021

Lymphocyte traffic control by chemokines

1 reference

7 January 2021

MIP-1alpha and MIP-1beta differentially mediate mucosal and systemic adaptive immunity

1 reference

7 January 2021

T cell costimulation by chemokine receptors

1 reference

7 January 2021

Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4+ T cell-dendritic cell interaction.

1 reference

7 January 2021

Macrophage inflammatory protein 1alpha inhibits postentry steps of human immunodeficiency virus type 1 infection via suppression of intracellular cyclic AMP.

1 reference

7 January 2021

The impact of early immune destruction on the kinetics of postacute viral replication in rhesus monkey infected with the simian-human immunodeficiency virus 89.6P.

1 reference

7 January 2021

Glancing behind virus load variation in HIV-1 infection

1 reference

7 January 2021

Prognosis in HIV-1 infection predicted by the quantity of virus in plasma

1 reference

7 January 2021

HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors

1 reference

7 January 2021

Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection

1 reference

7 January 2021

HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells

1 reference

7 January 2021

Both Serum HIV Type 1 RNA Levels and CD4+ Lymphocyte Counts Predict Clinical Outcome in HIV Type 1-Infected Subjects with 200 to 500 CD4+ Cells per Cubic Millimeter

1 reference

7 January 2021

Immunologic control of HIV-1.

1 reference

7 January 2021

In vivo delayed-type hypersensitivity skin test anergy in human immunodeficiency virus type 1 infection is associated with T cell nonresponsiveness in vitro

1 reference

7 January 2021

Does genotype mask the relationship between psychological factors and immune function?

1 reference

7 January 2021

Evolution of human and non-human primate CC chemokine receptor 5 gene and mRNA. Potential roles for haplotype and mRNA diversity, differential haplotype-specific transcriptional activity, and altered transcription factor binding to polymorphic nucle

1 reference

7 January 2021

HIV disease: fallout from a mucosal catastrophe?

1 reference

7 January 2021

What constitutes efficacy for a human immunodeficiency virus vaccine that ameliorates viremia: issues involving surrogate end points in phase 3 trials

1 reference

7 January 2021

Human genetics of infectious diseases: Fundamental insights from clinical studies

1 reference

7 January 2021

Low-level CD4+ T cell activation is associated with low susceptibility to HIV-1 infection

1 reference

7 January 2021

Pre-seroconversion immune status predicts the rate of CD4 T cell decline following HIV infection.

1 reference

7 January 2021

Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1.

1 reference

7 January 2021

The AIDS resistance of naturally SIV-infected sooty mangabeys is independent of cellular immunity to the virus

1 reference

7 January 2021

The effect of RANTES chemokine genetic variants on early HIV-1 plasma RNA among African American injection drug users.

1 reference

7 January 2021

KIR/HLA pleiotropism: protection against both HIV and opportunistic infections

1 reference

7 January 2021

A whole-genome association study of major determinants for host control of HIV-1

1 reference

7 January 2021

CCR5 deficiency is not protective in the early stages of atherogenesis in apoE knockout mice

1 reference

7 January 2021

Identifiers

DOI

10.1038/NI1521

1 reference

28 November 2017

1 reference